As of 9:55 a.m. on the 5th, group stocks including HLB are showing strength across the board, drawing investors' attention.

As of 9:55 a.m. on the same day, HLB is trading at 36,050 won, up 4.94% from the previous trading day. Affiliates are also joining in a coordinated rally. In particular, HLB Innovation (7.26%) and HLB Life Sciences (5.29%) are showing the most pronounced gains, while HLB Therapeutics (4.41%), HLB Global (3.83%), HLB Panagine (3.62%), and HLB Pharmaceutical (3.15%) are continuing their upward trends. With buying interest flowing into group stocks overall, centered on HLB, investment sentiment in the broader biotech sector is also improving.

At the same time, the domestic stock market is also exhibiting a strong upward trend. The KOSPI is currently at 6,580.78, up 221.83 points (3.48%) from the previous trading day, while the KOSDAQ is trading at 799.75, up 19.03 points (2.43%). The simultaneous rise in both major indices is restoring risk appetite, creating an environment where buying interest is spreading into the biotech sector.

Market attention is now focused on whether the current strength in HLB group stocks can be sustained, and whether the biotech sector can secure additional upward momentum in tandem with the domestic market's bullish trend.

[※ This article was written based on market prices as of 9:55 a.m., and intraday stock prices and indices are subject to change.]